Petr Jansky
Overview
Explore the profile of Petr Jansky including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
49
Citations
6431
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Marto J, Strambo D, Ntaios G, Nguyen T, Wrona P, Escalard S, et al.
J Stroke
. 2025 Feb;
27(1):128-132.
PMID: 39916463
No abstract available.
2.
Jansky P, Kaplan V, Sramkova T, Kolman F, Kloudova P, Benesova K, et al.
Medicine (Baltimore)
. 2024 Oct;
103(43):e40165.
PMID: 39470526
This study aimed to evaluate the ability of selected microRNAs as biomarkers of atrial fibrillation (AF) in ischemic stroke patients in comparison with other established biochemical biomarkers. A prospective case-control...
3.
Himmelreich J, Virdone S, Camm J, Pieper K, Harskamp R, Oto A, et al.
Open Heart
. 2024 Jul;
11(2).
PMID: 38955399
Background: The extent to which differences in results from Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) and Rivaroxaban Once Daily Oral Direct Factor Xa...
4.
Olserova A, Jansky P, Magerova H, Sramkova T, Kesnerova P, Kmetonyova S, et al.
Am J Ther
. 2024 Mar;
31(4):e362-e371.
PMID: 38525959
Background: Dabigatran directly inhibits thrombin and is used in primary and secondary stroke prevention in individuals with nonvalvular atrial fibrillation. The prodrug dabigatran etexilate is absorbed by enteral P-glycoprotein (ABCB1)...
5.
Pope M, Hall T, Virdone S, Atar D, Camm A, Pieper K, et al.
Int J Cardiol Heart Vasc
. 2023 Nov;
49:101302.
PMID: 38020059
Background: Investigate real-world outcomes of early rhythm versus rate control in patients with recent onset atrial fibrillation. Methods: The Global Anticoagulant Registry in the FIELD-AF (GARFIELD-AF) is an international multi-centre,...
6.
Garcia-Bernardo J, Jansky P, Torslov T
PLoS One
. 2023 Nov;
18(11):e0293552.
PMID: 38019736
Effective tax rates (ETRs) estimated from the income statement data of multinational corporations (MNCs) are useful for comparing MNCs' corporate income taxation across countries. In this paper, we propose a...
7.
Rehak Buckova B, Kala D, Korenek J, Matuskova V, Kumpost V, Svobodova L, et al.
PLoS One
. 2023 Apr;
18(4):e0280892.
PMID: 37058495
Despite the rising global burden of stroke and its socio-economic implications, the neuroimaging predictors of subsequent cognitive impairment are still poorly understood. We address this issue by studying the relationship...
8.
Haas S, Farjat A, Pieper K, Ageno W, Angchaisuksiri P, Bounameaux H, et al.
TH Open
. 2022 Dec;
6(4):e354-e364.
PMID: 36452204
Direct oral anticoagulants (DOACs) provide a safe, effective alternative to vitamin K antagonists (VKAs) for venous thromboembolism (VTE) treatment, as shown via intention-to-treat comparative effectiveness analysis. However, on-treatment analysis is...
9.
Marto J, Strambo D, Ntaios G, Nguyen T, Herzig R, Czlonkowska A, et al.
Neurology
. 2022 Nov;
100(7):e739-e750.
PMID: 36351814
Background And Objectives: COVID-19-related inflammation, endothelial dysfunction, and coagulopathy may increase the bleeding risk and lower the efficacy of revascularization treatments in patients with acute ischemic stroke (AIS). We aimed...
10.
Branch K, Dagenais G, Avezum A, Basile J, Conget I, Cushman W, et al.
Eur J Heart Fail
. 2022 Sep;
24(10):1805-1812.
PMID: 36073143
Aims: People with diabetes are at high risk for cardiovascular events including heart failure (HF). We examined the effect of the glucagon-like peptide 1 agonist dulaglutide on incident HF events...